- Trials with a EudraCT protocol (73)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
73 result(s) found for: Cleft.
Displaying page 1 of 4.
EudraCT Number: 2018-001457-28 | Sponsor Protocol Number: PI2018_843_0020 | Start Date*: Information not available in EudraCT |
Sponsor Name:CHU Amiens-Picardie | ||
Full Title: Analgesic contribution of the suprazygomatic maxillary nerve block after cleft palate surgery in children | ||
Medical condition: cleft palate repair surgery with or without upper lip surgery | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-004392-38 | Sponsor Protocol Number: R050187 | Start Date*: 2006-01-12 |
Sponsor Name:NHS Greater Glasgow/Glasgow University | ||
Full Title: The feasibility of using Bone Morphogenetic Protein (rhBMP-7) for reconstruction of alveolar cleft | ||
Medical condition: Autogenous bone graft harvested from the iliac crest is utilised as a gold standard for alveolar reconstruction. However, the harvesting of the bone graft is associated with morbidity which could ... | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2017-004130-28 | Sponsor Protocol Number: ZMK_201501-ONF | Start Date*: 2018-07-25 | |||||||||||
Sponsor Name:Universitätsklinikum Bonn | |||||||||||||
Full Title: Occurence of Oronasal Fistulas (ONF) using a fibrin sealant patch in primary palatoplasty | |||||||||||||
Medical condition: Cleft lip and palate | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-010918-30 | Sponsor Protocol Number: 2377 | Start Date*: 2009-08-11 | ||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Amar Agha, Beaumont Hospital | ||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Effect of growth hormone replacement on cortisol-to-cortisone interconversion in hypopituitary patients with growth hormone deficiency and the influence of different aetiologies of hypopituitarism. | ||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: 20 patients with hypopituitarism including growth hormone deficiency will be evaluated both on growth hormone replacement and when they have been off it for a 2 month period. They will have been pr... | ||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: IE (Ongoing) | ||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-022971-79 | Sponsor Protocol Number: PALO-10-14 | Start Date*: 2011-05-23 | ||||||||||||||||
Sponsor Name:Helsinn Healthcare SA | ||||||||||||||||||
Full Title: A Multicenter, Double-blind, Double-dummy, Randomized, Parallel Group, Stratified Study to Evaluate the Efficacy and Safety of a Single IV Dose of Palonosetron Compared to a Single IV Dose of Ondan... | ||||||||||||||||||
Medical condition: Postoperative nausea and vomiting (PONV) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: CZ (Completed) PL (Completed) HU (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-001667-85 | Sponsor Protocol Number: MDL_2020_10 | Start Date*: 2020-05-15 |
Sponsor Name:Hôpital Fondation Adolphe de Rothschild | ||
Full Title: A randomized controlled trial evaluating the efficacy of local budesonide therapy in the management of hyposmia in COVID-19 patients without signs of severity | ||
Medical condition: Patients with persistent hyposmia related to a SARS-CoV-2 infection | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-001786-34 | Sponsor Protocol Number: IT-04-01 | Start Date*: 2005-05-16 | |||||||||||
Sponsor Name:ALCON ITALIA | |||||||||||||
Full Title: Hypotonic efficacy and tollerability of Travoprost in patient with open angle primary glaucoma and/or ocular hypertension, not controlled with dorzolamide + timolol treatment in fixed association... | |||||||||||||
Medical condition: Reducing high intraocular pressure in patient with ocular hypertension or open-angle glaucoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-006005-61 | Sponsor Protocol Number: PRN 05-001 | Start Date*: 2006-03-16 | |||||||||||
Sponsor Name:Pharmaceutical Research Network, LLC | |||||||||||||
Full Title: A COMPARISON OF THE EFFICACY AND SAFETY OF THE DORZOLAMIDE/TIMOLOL FIXED COMBINATION GIVEN TWICE DAILY VERSUS THE LATANOPROST/TIMOLOL FIXED COMBINATION GIVEN ONCE EVERY MORNING FOLLOWING A RUN-IN... | |||||||||||||
Medical condition: open-angle glaucoma ocular hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SI (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002098-40 | Sponsor Protocol Number: LP0133-1182 | Start Date*: 2016-02-10 | |||||||||||
Sponsor Name:LEO Pharma A/S | |||||||||||||
Full Title: A Phase 2a, Proof of Concept Trial, testing twice daily application of LEO 124249 ointment 30mg/g in the treatment of mild to moderate inverse psoriasis | |||||||||||||
Medical condition: inverse psoriasis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022586-10 | Sponsor Protocol Number: SCO 5511 | Start Date*: 2011-05-05 | |||||||||||
Sponsor Name:Alfred E. Tiefenbacher (GmbH & Co. KG) | |||||||||||||
Full Title: Randomized, Double-Masked, Active Controlled, Crossover Phase III Equivalence Study of Travoprost Eye Drops Solution in Subjects with Open Angle Glaucoma or Ocular Hypertension | |||||||||||||
Medical condition: Open Angle Glaucoma or Ocular Hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001733-41 | Sponsor Protocol Number: 004,1 | Start Date*: 2013-06-12 | ||||||||||||||||
Sponsor Name:Harju Mika | ||||||||||||||||||
Full Title: Hypertonic saline - the effect of repeating doses | ||||||||||||||||||
Medical condition: Elevated eyepressure | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FI (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-009182-34 | Sponsor Protocol Number: DOR/2008 | Start Date*: 2009-03-30 | |||||||||||
Sponsor Name:ALFRED E. TIEFENBACHER (GMBH & CO. KG) | |||||||||||||
Full Title: RANDOMIZED, DOUBLE MASKED; ACTIVE CONTROLLED, CROSSOVER PHASE III EQUIVALENCE STUDY OF DORZOLAMIDE 2 % EYE DROPS SOLUTION IN SUBJECTS WITH OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION | |||||||||||||
Medical condition: Open angle glaucoma or ocular hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-024272-26 | Sponsor Protocol Number: GLC-05-10 | Start Date*: 2011-04-14 | |||||||||||
Sponsor Name:IRCCS- FONDAZIONE G.B. BIETTI PER LO STUDIO E LA RICERCA IN OFTALMOLOGIA-ONLUS | |||||||||||||
Full Title: Comparison of the effects of Bimatoprost 0.01% and Timolol 0.5% on circadian intraocular pressure | |||||||||||||
Medical condition: glaucoma and ocular hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-018853-36 | Sponsor Protocol Number: Cos_Gan_PR/09 | Start Date*: 2010-09-04 | |||||||||||
Sponsor Name:Prof. Stefano Gandolfi-Universita` degli studi di Parma | |||||||||||||
Full Title: Switching from beta blocker monotherapy to either ganfort � or cosopt �. A three months, single-blind , parallel group, randomized clinical trial in ocular hypertension/primary open angle glaucoma. | |||||||||||||
Medical condition: Primary open angle glaucoma or ocular hypertensive patients, any level of intraocular pressure. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002803-81 | Sponsor Protocol Number: TREX | Start Date*: 2020-04-03 | |||||||||||
Sponsor Name:IRCCS ISTITUTO GIANNINA GASLINI | |||||||||||||
Full Title: Neurodevelopmental outcome after standard dose sevoflurane versus low-dose sevoflurane/dexmedetomidine/remifentanil anaesthesia in young children | |||||||||||||
Medical condition: Children under the age of 2 years having surgery lasting at least 2 hours | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002601-30 | Sponsor Protocol Number: QTM/OMN0111 | Start Date*: 2011-09-26 | |||||||||||
Sponsor Name:OMNIVISION GmbH | |||||||||||||
Full Title: A COMPARISON OF LATANOPROST 50µg/ml EYE DROPS vs. XALATAN EYE DROPS IN THE TREATMENT OF OPEN ANGLE GLAUCOMA: AN OPEN, RANDOMIZED, CLINICAL TRIAL | |||||||||||||
Medical condition: Open angle glaucoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-022948-21 | Sponsor Protocol Number: RDG-10-246 | Start Date*: 2011-03-08 | ||||||||||||||||
Sponsor Name:Alcon Research, Ltd. | ||||||||||||||||||
Full Title: Eficacia y Seguridad de añadir Brinzolamida/Maleato de Timolol en combinación fija (Azarga ®) en pacientes con Hipertensión ocular o Glaucoma no controlados en Monoterapia de Prostaglandinas | ||||||||||||||||||
Medical condition: Hipertension ocular o glaucoma | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) AT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-011036-36 | Sponsor Protocol Number: C-01-78 | Start Date*: 2009-05-07 | ||||||||||||||||
Sponsor Name:Alcon Research, Ltd. | ||||||||||||||||||
Full Title: Estudio multicéntrico de la pigmentación en la red trabecular después de dos años de tratamiento con TRAVATAN 0,004% solución oftálmica. A multicenter study of the pigmentation in the trabecular me... | ||||||||||||||||||
Medical condition: Glaucoma de angulo abierto o hiperstensión ocular. Open-angle glaucoma or ocular hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-020746-98 | Sponsor Protocol Number: 77557 | Start Date*: 2010-11-01 | ||||||||||||||||
Sponsor Name:Santen Oy | ||||||||||||||||||
Full Title: An open-label phase IV study on the changes in ocular signs and symptoms in patients with ocular hypertension or open-angle glaucoma switched from preserved travoprost 0.004% eye drops to preservat... | ||||||||||||||||||
Medical condition: Patients diagnosed with Ocular Hypertension or Open-angle glaucoma (primary open-angle glaucoma [POAG] or capsular glaucoma) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-021039-14 | Sponsor Protocol Number: S001-2010 | Start Date*: 2010-08-19 | ||||||||||||||||
Sponsor Name:Tampere University, Faculty of Medicine, Department of Ophthalmology | ||||||||||||||||||
Full Title: An open-label, phase IV, pilot study, to evaluate confocal microscopic findings of cornea, ocular signs and symptoms in patients with ocular hypertension or open-angle glaucoma switching from latan... | ||||||||||||||||||
Medical condition: Ocular Hypertension (OH) or Open-Angle Glaucoma (OAG); primary open-angle glaucoma [POAG] or capsular glaucoma. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FI (Completed) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.